Search Ontology:
ChEBI
zavegepant
- Term ID
- CHEBI:229643
- Synonyms
-
- (R)-N-(3-(7-methyl-1H-indazol-5-yl)-1-(4-(1-methylpiperidin-4-yl)piperazin-1-yl)-1-oxopropan-2-yl)-4-(2-oxo-1,2-dihydroquinolin-3-yl)piperidine-1-carboxamide
- BHV 3500
- BHV-3500
- BHV3500
- BMS 742413
- BMS-742413
- BMS-742413-01
- N-{(2R)-3-(7-methyl-1H-indazol-5-yl)-1-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-1-oxopropan-2-yl}-4-(2-oxo-1,2-dihydroquinolin-3-yl)piperidine-1-carboxamide
- zavegepant
- zavegepantum
- Definition
- A member of the class of ureas that is urea in which both amino groups are replaced by 4-(2-oxo-1,2-dihydroquinolin-3-yl)piperidin-1-yl and {(2R)-3-(7-methyl-1H-indazol-5-yl)-1-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-1-oxopropan-2-yl}amino groups. It is a calcitonin gene-related peptide receptor antagonist whose hydrochloride salt has been approved by the FDA for the acute treatment of migraine.
- References
-
- cas:1337918-83-8
- drugbank:DB15688
- kegg.drug:D11898
- patent:US2012059017
- pubmed:23632269
- pubmed:33096162
- pubmed:35774914
- pubmed:36189708
- pubmed:36239038
- pubmed:36552072
- pubmed:36804093
- pubmed:37012363
- pubmed:37094060
- pubmed:37227596
- pubmed:37270693
- pubmed:37345774
- pubmed:37363553
- pubmed:37593294
- pubmed:37630989
- pubmed:37723470
- pubmed:37897226
- pubmed:37904462
- pubmed:38311738
- pubmed:38333255
- wikipedia.en:Zavegepant
- Ontology
- ChEBI ( EBI )
Phenotype
Phenotype resulting from zavegepant
Phenotype where environments contain zavegepant
Phenotype modified by environments containing zavegepant
Phenotype affecting zavegepant
Human Disease Model